DOYLE JOHN BRENDAN (Chief Financial Officer) reported 1 transaction at COGNITION THERAPEUTICS INC
Review the transaction codes below to understand the nature of each event.
Filed: 5/4/2026ACC: 0001104659-26-054858
Officer· Chief Financial Officer
Since Feb 2026
-8.57K
Net shares
Net seller
$11.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
8.57K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.57K
Price / share
$1.28
Trade value
$10.97K
% of position
1.4%
5/1/2026
627.51K→618.94K
Total
Net shares
−8.57K
Net value
-$10.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | F · Tax Withholding | −8.57K | $1.28 | $10.97K | 1.4% | 627.51K | 618.94K |
| Total | −8.57K | -$10.97K | ||||||
Derivative Transactions0
No derivative transactions reported